Vimarsana
Biggest News Aggregation in the World

Page 12 - Solara Active Pharma Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Solara Active Pharma Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Solara Active Pharma Sciences Today - Breaking & Trending Today

glenmark pharmaceuticals: Glenmark Life Sciences' IPO may ride the API wave. Challenges: scaling up and sustaining growth. - Vimarsana News

glenmark pharmaceuticals: Glenmark Life Sciences' IPO may ride the API wave. Challenges: scaling up and sustaining growth.

Glenmark manufacturing plant at Dahej, Gujarat; Image courtesy: Glenmark Synopsis The company’s performance has been robust — 16% CAGR in revenue and 17% CAGR in Ebitda over the last three years, and an Ebitda margin of over 30%. Besides, it has fared well in the critical parameter of quality compliance. It is now looking to expand its manufacturing capacity, product portfolio, and geographical presence, but can it continue its run? Active pharmaceutical ingredients (APIs) are the backbone of pharma industry. When the pandemic struck, cracks in the pharma supply chain were exposed, especi...

solara active pharma share price: Buy Solara Active Pharma Sciences, target price Rs 2000: Motilal Oswal - Vimarsana News

solara active pharma share price: Buy Solara Active Pharma Sciences, target price Rs 2000: Motilal Oswal

Explore Now Motilal Oswal has buy call on Solara Active Pharma Sciences with a target price of Rs 2000. The current market price of Solara Active Pharma Sciences is Rs 1710.4. Solara Active Pharma Sciences Ltd., incorporated in the year 2017, is a Small Cap company (having a market cap of Rs 5927.33 Crore) operating in Pharmaceuticals sector. Financials For the quarter ended 31-03-2021, the company reported a Consolidated Total Income of Rs 453.99 Crore, up 4.37 % from last quarter Total Income of Rs 434.98 Crore and up 46.97 % from last year same quarter Total Income of Rs 308.90 Crore. Co...

Solara Active Pharma spurts after Shivanand Shankar Mankekar buys stake - Vimarsana News

Solara Active Pharma spurts after Shivanand Shankar Mankekar buys stake

Solara Active Pharma Sciences rose 3.10% to Rs 1,698.80 after Shivanand Shankar Mankekar bought 8.70 lakh equity shares or 2.42% stake at Rs 1,552.05 per share of the company via bulk deal on NSE on Monday (10 May 2021). Pronomz Ventures sold 8.70 lakh equity shares of Solara Active Pharma at Rs 1,552.05 per share via bulk deal on NSE on Monday. Professor Shivanand Shankar Mankekar is a high net-worth investor (HNI) and a former full-time professor at Mumbai's Jamnalal Bajaj Institute of Management Studies. As per the bulk deal data on the BSE, Aditya Birla Sun Life Flexi Cap Fund bought 3,90...

Sensex, Nifty snap four day rising streak - Vimarsana News

Sensex, Nifty snap four day rising streak

Domestic indices saw profit taking after rising for four consecutive trading sessions on Tuesday. The Nifty 50 index ended near the 14,850 level. Metal, private banks corrected while media and PSU banks shares advanced. As per the provisional closing data, the barometer index, the S&P BSE Sensex, declined 340.6 points or 0.69% to 49,161.36. The Nifty 50 index fell 91.60 points or 0.61% at 14,850.10. The broader market outperformed the benchmark indices. The S&P BSE Mid-Cap index rose 0.6% while the S&P BSE Small-Cap index added 0.8%. Buyers outpaced sellers. On the BSE, 1,845 shares rose and...

SGX Nifty indicates positive note for Indian indices - Vimarsana News

SGX Nifty indicates positive note for Indian indices

SGX Nifty indicates positive note for Indian indices File Image The benchmark Indices are expected to open on a positive note as indicated by trends on SGX Nifty. US Indices closed with gains as Dow Jones hits a fresh new all-time high and Asian markets also opened stronger with Nikkei trading 2 percent higher. Key companies announcing their quarterly results today includes Adani Power, Coforge, Hero MotoCorp, Adani Transmission, P&G Health, Bluestar, Praj Industries and Tata Consumer. Immediate support and resistance for Nifty 50 are 14,500 and 14,800 respectively, said Mohit Nigam, Head-PMS...